Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Generation time of the Alpha and Delta SARS-CoV-2 variants

WS Hart, E Miller, NJ Andrews, P Waight, PK Maini, S Funk, View ORCID ProfileRN Thompson
doi: https://doi.org/10.1101/2021.10.21.21265216
WS Hart
1Mathematical Institute, University of Oxford, Oxford, OX2 6GG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Miller
2Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
3Immunisation and Countermeasures Division, UK Health Security Agency, London, NW9 5EQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NJ Andrews
4Data and Analytical Sciences, UK Health Security Agency, London, NW9 5EQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Waight
3Immunisation and Countermeasures Division, UK Health Security Agency, London, NW9 5EQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PK Maini
1Mathematical Institute, University of Oxford, Oxford, OX2 6GG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Funk
2Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RN Thompson
5Mathematics Institute, University of Warwick, Coventry, CV4 7AL, UK
6Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Coventry, CV4 7AL, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for RN Thompson
  • For correspondence: Robin.N.Thompson@warwick.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Background In May 2021, the Delta SARS-CoV-2 variant became dominant in the UK. This variant is associated with increased transmissibility compared to the Alpha variant that was previously dominant. To understand ongoing transmission and interventions, a key question is whether the Delta variant generation time (the time between infections in infector- infectee pairs) is typically shorter–i.e., transmissions are happening more quickly–or whether infected individuals simply generate more infections.

Methods We analysed transmission data from a UK Health Security Agency household study. By fitting a mathematical transmission model to the data, we estimated the generation times for the Alpha and Delta variants.

Results The mean intrinsic generation time (the generation time if there had been a constant supply of susceptibles throughout infection) was shorter for the Delta variant (4·6 days, 95% CrI 4·0-5·4 days) than the Alpha variant (5·5 days, 95% CrI 4·6-6·4 days), although within uncertainty ranges. However, there was a larger difference in the realised mean household generation time between the Delta (3·2 days, 95% CrI 2·4-4·2 days) and Alpha (4·5 days, 95% CrI 3·7-5·4 days) variants. This is because higher transmissibility led to faster susceptible depletion in households, in addition to the reduced intrinsic generation time.

Conclusions The Delta variant transmits more quickly than previously circulating variants. This has implications for interventions such as contact tracing, testing and isolation, which are less effective if the virus is transmitted quickly. Epidemiological models of interventions should be updated to include the shorter generation time of the Delta variant.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

WSH was funded by an EPSRC Excellence Award for his doctoral studies (Grant Reference EP/R513295/1). EM receives support from the National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with the UKHSA (Grant Reference NIHR200929). SF receives funding from the Wellcome Trust (Grant Reference 210758/Z/18/Z). RNT receives support from the UKRI (Grant Reference EP/V053507/1).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The household surveillance protocol was approved by the UKHSA Research Ethics and Governance Group as part of the portfolio of the UKHSA's enhanced surveillance activities in response to the pandemic. Oral informed consent for sampling and follow up was obtained by the nurses from household members who were free to decline to participate in the surveillance at any time. Consent for children was obtained by a parent or legal guardian. Only anonymised data were provided to non-UKHSA authors.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced are available online at https://github.com/will-s-hart/variant_generation_times.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted October 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Generation time of the Alpha and Delta SARS-CoV-2 variants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Generation time of the Alpha and Delta SARS-CoV-2 variants
WS Hart, E Miller, NJ Andrews, P Waight, PK Maini, S Funk, RN Thompson
medRxiv 2021.10.21.21265216; doi: https://doi.org/10.1101/2021.10.21.21265216
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Generation time of the Alpha and Delta SARS-CoV-2 variants
WS Hart, E Miller, NJ Andrews, P Waight, PK Maini, S Funk, RN Thompson
medRxiv 2021.10.21.21265216; doi: https://doi.org/10.1101/2021.10.21.21265216

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (156)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8534)
  • Forensic Medicine (4)
  • Gastroenterology (381)
  • Genetic and Genomic Medicine (1739)
  • Geriatric Medicine (167)
  • Health Economics (370)
  • Health Informatics (1234)
  • Health Policy (618)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (369)
  • Infectious Diseases (except HIV/AIDS) (10271)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1666)
  • Nursing (97)
  • Nutrition (247)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (925)
  • Ophthalmology (262)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (110)
  • Palliative Medicine (40)
  • Pathology (249)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (205)
  • Psychiatry and Clinical Psychology (1757)
  • Public and Global Health (3826)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (317)
  • Respiratory Medicine (518)
  • Rheumatology (207)
  • Sexual and Reproductive Health (164)
  • Sports Medicine (156)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (100)
  • Urology (74)